Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Technology Breakthrough in Deep Light Imaging to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 13 Jul 2023

Optical coherence tomography (OCT), an important form of light imaging, operates on the principle of light backscattering within the sample under observation, similar to how light gets scattered in fog due to water droplets possessing different refractive indices than the air. More...

Just as the scattering makes it hard to see through fog, the scattering by cellular components and smaller constituents in biological tissue also complicates imaging tasks. Specifically, acquiring a clear signal from depths surpassing 1mm presents significant difficulties, chiefly because of intervening tissue. Now, a technological breakthrough in OCT is set to revolutionize applications in fields like ophthalmology, dermatology, cardiology, and early cancer detection, as well as improve disease diagnosis.

Traditional understanding holds that the OCT signal is largely influenced by light that has experienced a single backscattering event, while light that has been scattered numerous times hampers image creation. An international team of researchers, in collaboration with the University of St Andrews (Scotland, UK), have uncovered a contrasting perspective. They suggest that selectively gathering multiply scattered light could enhance image contrast at depth, especially in highly scattering samples. The researchers further demonstrated how this technique could be applied in a simple way with minimal additional optics, by shifting the light delivery and collection pathways. The team is confident that their ground-breaking discovery has the potential to challenge existing conventions and bring about a significant shift in retrieving images at depth.

“The unique configuration, supported by our modeling, should redefine our view on OCT signal formation – and we can now use this insight to extract more information and to improve diagnosis of disease,” said Dr. Peter Andersen, co-corresponding author from Technical University of Denmark.

Related Links:
University of St Andrews 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.